Table 4 Comparison of hypertension associated measures in males and females residents of Yazd Greater area according to JNC7 and ACC/AHA 2017 guidelines 2014–2015
Hypertension Prevalence by BP measurement | JNC 7 Num. (%, CI 95%) | ACC/AHA2017 Num. (%, CI 95%) | Difference % |
|---|---|---|---|
Male (N:4883) | |||
 Normal | 978 (20.0,18.9–21.2) | 978 (20.0,18.9–21.2) | 0 |
 Pre-hypertension/elevated blood | 2320 (47.5,46.1–48.9) | 613 (12.6,11.6–13.5) | - 34.9 |
 Stage-1 hypertension | 1075 (22.0,20.9–23.2) | 1707 (35.0,33.6–36.3) | +  13 |
 Stage-2 hypertension | 510 (10.4,9.6–11.3) | 1585 (32.5,31.2–33.8) | +  22.1 |
 Hypertension (stage-1 plus stage-2) | 1585 (32.4,31.2–33.8) | 3292 (67.4,66.1–68.7) | +  35.0 |
Female (N:4978) | |||
 Normal | 1642 (33.0,31.7–34.3) | 1642 (33.0,31.7–34.3) | 0 |
 Pre-hypertension/elevated blood | 2079 (41.8,40.4–43.1) | 608 (12.2,11.3–13.1) | −29.6 |
 Stage-1 hypertension | 854 (17.2,16.1–18.2) | 1471 (29.6,28.3–30.8) | +  12.4 |
 Stage-2 hypertension | 403 (8.1,7.4–8.9) | 1257 (25.2,24.1–26.5) | +  17.1 |
 Hypertension (stage-1 plus stage-2) | 1257 (25.3,24.1–26.5) | 2728 (54.8,53.4–56.2) | +  29.5 |
Total | |||
 Normal | 2620 (26.6,25.7–27.4) | 2620 (26.6,25.7–27.4) | 0 |
 Pre-hypertension/elevated blood | 4399 (44.6,43.6–45.6) | 1221 (12.4,11.7–13.0) | −32.2 |
 Stage-1 hypertension | 1929 (19.6,18.8–20.3) | 3178 (32.2,31.3–33.2) | +  12.6 |
 Stage-2 hypertension | 913 (9.3,8.7–9.8) | 2842 (28.8,27.9–29.7) | +  19.5 |
 Hypertension (stage-1 plus stage-2) | 2842 (28.9,27.9–29.7) | 6020 (61.0,60.1–62.0) | +  32.1 |